News

Filter

Current filters:

BiotechnologyLicensing

226 to 235 of 95890 results

Ziopharm and Solasia amend collaboration for darinaparsin

Ziopharm and Solasia amend collaboration for darinaparsin

01-08-2014

US drug developer Ziopharm Oncology and Japan’s Solasia Pharma, a developer of oncology pharmaceuticals…

darinaparsinGlobalLicensingOncologyPharmaceuticalSolasia PharmaZinaparZiopharm Oncology

French regulators push for huge cut in hypnotic benzodiazepine reimbursement

French regulators push for huge cut in hypnotic benzodiazepine reimbursement

01-08-2014

French regulators are attempting to discourage the over-consumption and misuse of hypnotic benzodiazepines…

diazepamFranceFrench governmentNeurologicalPharmaceuticalRegulation

This week’s pharma financial results in brief

This week’s pharma financial results in brief

01-08-2014

A whole host of pharma, biotech and generics companies released second quarter and first half results…

FinancialGlobal

UK aims to become world number one in DNA testing with new investment

UK aims to become world number one in DNA testing with new investment

01-08-2014

David Cameron, the UK Prime Minister, has announced a package of investment worth more than £300 million…

BiotechnologyDavid CameronGeneticsIlluminaMedical Research CouncilResearchUK

FDA advisory panel backs Baxter’s HyQvia for primary immunodeficiency

FDA advisory panel backs Baxter’s HyQvia for primary immunodeficiency

01-08-2014

The Blood Products Advisory Committee of the US Food and Drug Administration has voted 15-1 that HyQvia…

Baxter InternationalBiotechnologyHalozyme TherapeuticsHyQviaImmunologicalsRegulationUS Food and Drug AdministrationUSA

USA’s 340B Drug Discount Program “needs more oversight,” says BIO

USA’s 340B Drug Discount Program “needs more oversight,” says BIO

01-08-2014

The US Biotechnology Industry Organization’s (BIO) Laurel Todd shared concerns that the 340B program…

BiotechnologyFinancialHealthcareRegulationUSA

Kyowa Hakko Kirin files for KW-3357 approval in Japan

Kyowa Hakko Kirin files for KW-3357 approval in Japan

01-08-2014

Japanese drugmaker Kyowa Hakko Kirin has filed an application for marketing approval with the Ministry…

HematologyJapanKW-3357Kyowa Hakko KirinPharmaceuticalRare diseasesRegulationThrombus

226 to 235 of 95890 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top